Silk Road Medical

General Information

We are a medical device company focused on reducing the risk of stroke and its devastating impact. We believe a key to stroke prevention is minimally invasive and technologically advanced intervention to safely and effectively treat carotid artery disease, one of the leading causes of stroke. We have pioneered a new approach for the treatment of carotid artery disease called transcarotid artery revascularization, or TCAR, which we seek to establish as the standard of care. TCAR relies on two novel concepts – minimally invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain – and combines the benefits of innovative endovascular techniques with fundamental surgical principles.

Employees: 176
Founded: 2007
Contact Information
Address 1213 Innsbruck Drive, Sunnyvale, CA 94089, US
Phone Number (408) 720-9002
Web Address
View Prospectus: Silk Road Medical
Financial Information
Market Cap $604.6mil
Revenues $34.6 mil (last 12 months)
Net Income $-37.6 mil (last 12 months)
IPO Profile
Symbol SILK
Exchange NASDAQ
Shares (millions): 6.0
Price range $20.00 - $20.00
Est. $ Volume $120.0 mil
Manager / Joint Managers J.P. Morgan/ BofA Securities
CO-Managers BMO Capital Markets/ Stifel
Expected To Trade: 4/4/2019
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change